BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32511303)

  • 1. Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity.
    Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
    bioRxiv; 2020 Oct; ():. PubMed ID: 32511303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
    Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
    J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
    Carter-O'Connell I; Cohen MS
    Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner.
    Kerr CM; Parthasarathy S; Schwarting N; O'Connor JJ; Pfannenstiel JJ; Giri E; More S; Orozco RC; Fehr AR
    J Virol; 2023 Sep; 97(9):e0088523. PubMed ID: 37695054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms governing PARP expression, localization, and activity in cells.
    Sanderson DJ; Cohen MS
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Clickable NAD
    Zhang L; Lin H
    Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
    Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
    PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD
    Tan A; Doig CL
    Front Mol Biosci; 2021; 8():697359. PubMed ID: 34485381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide.
    Badawy AA
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33063092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.
    Voth LS; O'Connor JJ; Kerr CM; Doerger E; Schwarting N; Sperstad P; Johnson DK; Fehr AR
    J Virol; 2021 Jul; 95(15):e0076621. PubMed ID: 34011547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation.
    Gibson BA; Zhang Y; Jiang H; Hussey KM; Shrimp JH; Lin H; Schwede F; Yu Y; Kraus WL
    Science; 2016 Jul; 353(6294):45-50. PubMed ID: 27256882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.
    Alhammad YMO; Fehr AR
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32244383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between compartmentalized NAD
    Cohen MS
    Genes Dev; 2020 Mar; 34(5-6):254-262. PubMed ID: 32029457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When PARPs Meet Antiviral Innate Immunity.
    Zhu H; Zheng C
    Trends Microbiol; 2021 Sep; 29(9):776-778. PubMed ID: 33483164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell and tissue specific manner.
    Kerr CM; Parthasarathy S; Schwarting N; O'Connor JJ; Giri E; More S; Orozco RC; Fehr AR
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Genomic Sites of ADP-Ribosylation Mediated by Specific Nuclear PARP Enzymes Using Click-ChIP.
    Rogge RA; Gibson BA; Kraus WL
    Methods Mol Biol; 2018; 1813():371-387. PubMed ID: 30097881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Taipakova S; Kuanbay A; Saint-Pierre C; Gasparutto D; Baiken Y; Groisman R; Ishchenko AA; Saparbaev M; Bissenbaev AK
    Front Cell Dev Biol; 2020; 8():606596. PubMed ID: 33324653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases.
    Jiang H; Kim JH; Frizzell KM; Kraus WL; Lin H
    J Am Chem Soc; 2010 Jul; 132(27):9363-72. PubMed ID: 20560583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.